Option Care Health Q4 2023 Earnings Report

Option Care Health EPS Results

• Actual EPS: $0.32
• Consensus EPS: $0.29
• Beat/Miss: Beat by +$0.03
• One Year Ago EPS: $0.26

Option Care Health Revenue Results

• Actual Revenue: $1.12 billion
• Expected Revenue: $1.09 billion
• Beat/Miss: Beat by +$36.04 million
• YoY Revenue Growth: +9.50%

Option Care Health Announcement Details

• Quarter: Q4 2023
• Date: 2/22/2024
• Time: Before Market Opens

Option Care Health (NASDAQ:OPCH) offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.